Independent & educational platform Not a government body. No link or affiliation with any government organisation. Made for learning only. Test only systems you own or are authorised to test. Become a Partner or Sponsor → Full disclaimer

CVE-2026-42423

high

OpenClaw before 2026.4.8 contains an approval-timeout fallback mechanism that bypasses strictInlineEval explicit-approval requirements on gateway and node exec…

Vendor / product: Openclaw — openclaw

OpenClaw before 2026.4.8 contains an approval-timeout fallback mechanism that bypasses strictInlineEval explicit-approval requirements on gateway and node exec hosts. Attackers can exploit this timeout fallback to execute inline eval commands that should require explicit user approval, circumventing the intended security boundary.

CVSS
7.5
7.5 (CVSS v3.1)
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:H/I:H/A:H
Severity source: NVD CVSS v3.1 (disclosure@vulncheck.com)
Timeline (UTC)
Published: 2026-04-28 19:37
Modified: 2026-11-11 21:10
NVD status: Analyzed
Last synced 5 hours ago
Verified against the source API 2026-11-11 21:11 UTC
Exploitation
Not listed in CISA KEV (as of last catalog sync)
Absence from KEV does not mean a CVE is not exploited. Exploitation status: unknown (no authoritative evidence in our sources).

Affected products

openclaw / openclaw <2026.4.8

Weakness classification (CWE)

Source: NVD / CISA. “NVD-CWE-Other” and “NVD-CWE-noinfo” mean NVD could not assign a specific weakness.

Mitigation & advisories

Vendor advisory: https://github.com/openclaw/openclaw/security/advisories/GHSA-q2gc-xjqw-qp89
Patch / mitigation: https://github.com/openclaw/openclaw/commit/d7c3210cd6f5fdfdc1beff4c9541673e814354d5

References

Data sources

NVD CVE API 2.0 — fetched 2026-11-11 21:11 UTC · record ↗

Learn the basics

Understanding CVEs and CVSS Scores

Related CVEs